SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Theriva Biologics Q3 2026 Net Loss Narrows 66% to $1.47 Million

Theriva Biologics Q3 2026 Net Loss Narrows 66% to $1.47 Million Theriva Biologics’ third-quarter

TOVX

Related stories